<DOC>
	<DOCNO>NCT02821156</DOCNO>
	<brief_summary>This prospective , observational , multicenter study conduct 1 year adult paediatric intensive care unit equip EZ-KINOX™ system . A maximum 250 patient ( newborns adult , suffer Pulmonary Arterial Hypertension ( PAH ) associate cardiac surgery Persistent Pulmonary Hypertension Newborn ( PPHN ) receive iNO integrated delivery monitor EZ-KINOX™ system plan include . The study strictly non-interventional aim describe current practice therefore affect patient usual management .</brief_summary>
	<brief_title>Study Use Inhaled NO ( iNO )</brief_title>
	<detailed_description>This study intend describe daily practice therefore , standardize protocol patient-based site-based questionnaire .</detailed_description>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Newborn &gt; = 34 week gestational age suffer hypoxic respiratory failure pulmonary hypertension ( France ) patient present postoperative pulmonary hypertension associate cardiac surgery ( France Belgium ) · Patient treat iNO deliver EZKINOX™ Newborn dependent righttoleft shunt `` malignant '' leftright arterial canal Newborn Glucose6Phosphate Dehydrogenase ( G6PD ) deficiency .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>